Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BETAS: Beta-hCG + Erythropoietin in Acute Stroke
NCT00362414Phase 2Completed
- Sponsor
- University of California, Irvine
- Start
- Aug 2006
- Primary completion
- Mar 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of human chorionic gonadotropin and erythropoietin in ischemic stroke, sponsored by University of California, Irvine. Primary endpoints: Safety at 3 months, Morbidity at 3 months and 1 more. Started Aug 2006; status: completed.
02
Drugs
human chorionic gonadotropinerythropoietin
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT00362414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00362414.